TechDogs-"Leal Health Presents Poster Highlighting Disparities In Clinical Trial Participation Among Diverse Ethnic Groups"

Health Care Technology

Leal Health Presents Poster Highlighting Disparities In Clinical Trial Participation Among Diverse Ethnic Groups

By PR Newswire

PR Newswire
Overall Rating

Findings Unveiled at AACR Conference on The Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved

NEW YORK, Oct. 10, 2023 /PRNewswire/ -- Leal Health ("Leal'' or the "Company''), formerly known as Trialjectory, an AI-powered treatment decision support platform that democratizes patient access to advanced cancer treatments and empowers the pharmaceutical and biotech industry to execute patient-centric clinical trials, announced today that it presented a poster highlighting disparities in clinical trial participation among diverse ethnic communities at this year's American Association for Cancer Research (AACR) Conference on The Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved.

The poster, titled, "Unveiling disparities in clinical trial participation: Exploring socioeconomic barriers and access to insurance among diverse ethnic groups," was presented by Ritta Jubran, Medical Director at Leal Health, and highlighted data from a multi-ethnic cohort of 4,525 new patient sign-ups in 2023. The study focused on the impact of several socioeconomic factors, such as insurance coverage and patients' willingness to travel to clinical trial locations, to identify obstacles within underserved communities that contribute to patients' underrepresentation in trials.

Key findings from the study include:

  • Non-white patients were more likely to be uninsured compared to white patients.
  • Medicaid exhibited the highest diversity among insurance providers, representing 33 percent of the cohort.
  • Leal's platform draws a diverse range of patients, with 26 percent of users identifying as non-white.
  • Non-white patients showed a preference for shorter travel distances when seeking clinical trials.
    • Fifty percent of non-white patients limited their search radius for clinical trials to 50 miles, compared to 42 percent of white patients.
    • Thirteen percent of non-white patients were willing to travel more than 50 miles, while 22 percent of white patients were open to traveling longer distances.

"Our findings from this study reinforce the urgent need to tackle socioeconomic challenges that prevent greater accessibility and inclusivity in clinical trials, especially for historically underrepresented patient communities," said Tzvia Bader, CEO and Co-Founder, Leal Health. "Achieving true, real-world representation in clinical trials is a crucial step toward ensuring equity in healthcare. In fact, last year, the U.S. Food and Drug Administration (FDA) released guidance for the healthcare industry to enroll more participants from underrepresented racial and ethnic populations into clinical trials. The only way to deliver effective cancer treatments for all patients, regardless of their socioeconomic background or ethnicity, is to remove the barriers that contribute to underrepresentation once and for all."

Ms. Bader added, "Utilizing a platform like Leal, the industry can no longer hide behind its claims that diverse patients are not exposed to — or willing to — enroll in clinical trials. With over 40 percent of the 150,000+ patients in the Leal community who come from diverse ethnic groups, we have the tools and data to help pharma identify the real barriers and help mitigate these issues that will, in turn, improve accessibility and participation of more diverse patient populations in clinical trials."

About Leal Health

Leal Health, formerly known as Trialjectory, is a patient-first, AI-powered treatment decision support platform dedicated to improving cancer care. Working directly with patients, healthcare providers and pharmaceutical companies, Leal democratizes access to advanced cancer treatment and empowers the pharmaceutical and biotech industry to execute patient-centric clinical trials. The Company has been recognized by TIME as one of "The 100 Best Inventions of 2020" and named an honoree in the AI and data category for Fast Company's "2021 World-Changing Ideas Awards." For more information, please visit www.leal.health, and follow the Company on Facebook and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/leal-health-presents-poster-highlighting-disparities-in-clinical-trial-participation-among-diverse-ethnic-groups-301951184.html

SOURCE Leal Health

First published on Tue, Oct 10, 2023

Enjoyed what you read? Great news – there’s a lot more to explore!

Dive into our content repository of the latest tech news, a diverse range of articles spanning introductory guides, product reviews, trends and more, along with engaging interviews, up-to-date AI blogs and hilarious tech memes!

Also explore our collection of branded insights via informative white papers, enlightening case studies, in-depth reports, educational videos and exciting events and webinars from leading global brands.

Head to the TechDogs homepage to Know Your World of technology today!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs’ members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs’ Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. All information / content found on TechDogs’ site may not necessarily be reviewed by individuals with the expertise to validate its completeness, accuracy and reliability.

Tags:

Leal Health Pharmaceutical And Biotech Industry Healthcare Providers AI-powered Treatment

References:

Join The Discussion

  • Dark
  • Light